Loading
Latest filing published 01 Jul 2026 for Oramed Pharmaceuticals INC., €395k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 1 July 2026, Gabay Avraham disclosed a transaction of €395k in Oramed Pharmaceuticals Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration